drugset
drugset / Trial / NCT01202734

A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers

NCT01202734 ↗

Phase 1 Completed 10 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Non-randomizedSingle-groupOpen-label

Summary

The purpose of the study is to evaluate the pharmacokinetics and safety of 3 single doses of Methylphenidate HCl in healthy Japanese adult male volunteers.

Timeline

Start
2010-09
Primary completion
2010-10
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 36 mg Oral
Subject Methylphenidate Small molecule 54 mg Oral
Subject Methylphenidate Small molecule 72 mg Oral

Indications

No indication recorded.